Privia Health Group: Leerink Partners cuts target price to $34 from $40
PRVA•Leerink Partners cut its target price for Privia Health Group to $34 from $40.
Related News
Sarepta Therapeutics: RBC raises target price to $18 from $17
SRPT•
Shinhan Financial Group to attend Samsung Securities investor conference
SHG•
Analysts and investors react to AI market rout
QQQ•
Middleby target price raised to $160 from $152 by Canaccord Genuity
MIDD•
Enact Holdings raises target price to $45 from $44
ACT•